<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2009</study_start_year><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><condition>Breast Cancer</condition><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><disease>Breast Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2065602</full_dataset_link><location>France</location><study_start_month>1</study_start_month><keyword>Colorectal metastatic cancer</keyword><keyword>Breast metastatic cancer</keyword><keyword>Capecitabine</keyword><keyword>Pharmacocinetics</keyword><keyword>Elderly patients</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)</name><description>The aim of the study is to determine blood concentration evolution of capecitabine and its active metabolites, in elderly patient 75 years and more.</description><dates><creation>2009-01-15</creation></dates><accession>2065602</accession><cross_references><ClinicalTrials___gov>NCT00812864</ClinicalTrials___gov></cross_references></HashMap>